RECURSION PHARMACEUTICALS-A Share Price Today: Live Updates & Key Insights
RECURSION PHARMACEUTICALS-A share price today is $3.25, up -3.56%. The stock opened at $3.335 against the previous close of $3.37, with an intraday high of $3.415 and low of $3.215.
RECURSION PHARMACEUTICALS-A Share Price Chart
RECURSION PHARMACEUTICALS-A
RECURSION PHARMACEUTICALS-A Share Price Performance
RECURSION PHARMACEUTICALS-A Institutional Holdings
RECURSION PHARMACEUTICALS-A Market Status
RECURSION PHARMACEUTICALS-A Fundamentals
Market Cap 1716.66 M
PB Ratio 1.525
PE Ratio 0.0
Enterprise Value 1059.25 M
Total Assets 1474.13 M
Volume 26878031
RECURSION PHARMACEUTICALS-A Company Financials
About RECURSION PHARMACEUTICALS-A & investment objective
Company Information Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-1245, which is in Phase 1/2 clinical trial to treat biomarker-enriched solid tumors and lymphoma; REC-3565 that is in Phase 1/2 for the treatment of relapsed or refractory B-cell malignancies; and REC-4539, a reversible, CNS penetrant, orally bioavailable, and potential best-in-class inhibitor of LSD1 for the treatment of solid tumors and hematology oncology. Its preclinical stage product includes REC-7735 for the treatment of HR+ breast cancer; and REC-102 for the treatment of hypophosphatasia. The company has collaboration and agreement with Roche & Genentech; Sanofi; Bayer AG; Tempus; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Organisation Biotechnology
Employees 600
Industry Biotechnology
CEO Dr. Najat Khan Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
RECURSION PHARMACEUTICALS-A FAQs
What is the share price of RECURSION PHARMACEUTICALS-A today?
The current share price of RECURSION PHARMACEUTICALS-A is $3.25.
Can I buy RECURSION PHARMACEUTICALS-A shares in India?
Yes, Indian investors can buy RECURSION PHARMACEUTICALS-A shares by opening an international trading and demat account with Motilal Oswal.
How to buy RECURSION PHARMACEUTICALS-A shares in India?
You can easily invest in RECURSION PHARMACEUTICALS-A shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy RECURSION PHARMACEUTICALS-A shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of RECURSION PHARMACEUTICALS-A.
Can I buy fractional shares of RECURSION PHARMACEUTICALS-A?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of RECURSION PHARMACEUTICALS-A?
RECURSION PHARMACEUTICALS-A has a market cap of $1716.66 M.
In which sector does RECURSION PHARMACEUTICALS-A belong?
RECURSION PHARMACEUTICALS-A operates in the Biotechnology sector.
What documents are required to invest in RECURSION PHARMACEUTICALS-A stocks?
To invest, you typically need:
What is the PE and PB ratio of RECURSION PHARMACEUTICALS-A?
The PE ratio of RECURSION PHARMACEUTICALS-A is N/A and the PB ratio is 1.53.